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Abstract: Elucidating the biological and biochemical roles of proteins, and subsequently
determining their interacting partners, can be difficult and time consuming using in vitro and/or
in vivo methods, and consequently the majority of newly sequenced proteins will have unknown
structures and functions. However, in silico methods for predicting protein–ligand binding sites
and protein biochemical functions offer an alternative practical solution. The characterisation of
protein–ligand binding sites is essential for investigating new functional roles, which can impact the
major biological research spheres of health, food, and energy security. In this review we discuss the
role in silico methods play in 3D modelling of protein–ligand binding sites, along with their role in
predicting biochemical functionality. In addition, we describe in detail some of the key alternative
in silico prediction approaches that are available, as well as discussing the Critical Assessment
of Techniques for Protein Structure Prediction (CASP) and the Continuous Automated Model
EvaluatiOn (CAMEO) projects, and their impact on developments in the field. Furthermore, we
discuss the importance of protein function prediction methods for tackling 21st century problems.
Keywords: protein–ligand binding site prediction; protein function prediction; binding-site residue
prediction; biochemical functional elucidation; sequence-based function prediction; structure-based
function prediction; biological and biochemical role of enzymes; gene Ontology; enzyme
commission numbers
1. Introduction
Proteins are essential molecules involved in a wide variety of essential intra- and inter-cellular
activities. These activities include, but are not limited to: maintaining cellular defences, enzymatic
catalysis, metabolism and catabolism, maintenance of the structural integrity of cells, and signalling
within and between cells. Furthermore, protein–ligand interactions are essential for biochemical
functionality and are implicated in all biochemical roles, in all kingdoms of life. Hence, studying
protein–ligand binding sites and their associated residues, is an important step in the functional
elucidation of proteins involved in these cellular processes [1–4].
Understanding protein–ligand interactions in the context of protein–ligand binding sites and
ligand binding site residues is important for fully understanding cellular mechanisms, and is critical
for understanding responses to drugs. Methods for the prediction of protein–ligand binding sites,
which are detailed in the following section, can greatly enhance our understanding of the molecular
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mechanisms involved in many research spheres, helping us tackle numerous 21st century problems.
The effects of protein–ligand binding are transient, but this knowledge can be exploited for the
treatment of human and animal diseases, in addition to impacting food security research, examples
of which are highlighted in Figure 1 and discussed in Section 6.
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Figure 1. Examples of protein–ligand interactions, focusing on the ligand binding site. Proteins are 
shown in cartoon form and coloured in light grey, with binding site residues shown as blue sticks, 
and ligands shown as sticks or spheres coloured by element; (A) The Human cytochrome P450 1A1 
protein (PDB ID 4i8v) bound to the drug N-Benzylformamide; (B) Cyclooxygenase-2 (PDB ID 4ph9) 
from Mus musculus bound to the drug Ibuprofen; (C) The Plasmodium vivax TRAP protein (PDB ID 
4hqo, CASP ID T0686) bound to magnesium and; (D) The aminopeptidase N family protein Q5QTY1 
(PDB ID 4fgm, CASP ID T0726) from Idiomarina loihiensis bound to zinc (a cofactor). 
We begin by briefly highlighting some key protein–ligand interactions from a biomedical 
perspective. In Figure 1 we focus on four examples of proteins bound to diverse types of ligands, 
which are important in health and disease. This includes Cytochrome P450 bound to the drug N-
Benzylformamide (Figure 1A—PDB ID 4i8v). The enzyme Cytochrome P450 has an essential role in 
the electron transfer chain, and is therefore ubiquitous in all kingdoms of life [5]. The human 
Cytochrome P450 (CYP1A1) is known to play a role in the biotransformation of polycyclic aromatic 
hydrocarbons into carcinogens [6]. In addition, CYP1A1 (PDB ID 4i8v) is responsible for the 
metabolism of theophylline [7], a drug used to provide symptomatic relief from asthma. 
Cyclooxygenase-2 from Mus musculus, which is involved in the biosynthesis of prostaglandins, is a 
target of non-steroidal anti-inflammatory drugs such as Ibuprofen (Figure 1B). The Plasmodium vivax 
TRAP protein, bound to magnesium, is involved in phosphate ester hydrolysis (Figure 1C). Finally, 
Figure 1D shows the protein–ligand binding site of the aminopeptidase N family protein Q5QTY1, 
from Idiomarina loihiensis bound to zinc (its cofactor), which can be used as a biomarker to detect 
kidney damage. 
This review aims to provide an overview of the variety of different methodologies available for 
the prediction of protein–ligand binding sites and their associated binding site residues. Here we will 
focus on computational methods developed in the last six years, since the inclusion of the function 
prediction (FN) category in the Critical Assessment of Techniques for Protein Structure Prediction 
(CASP) competition [8]. For methods developed before 2010, please refer to the review by Kaufmann 
and Karypis [9]. Furthermore, molecular docking methods are beyond the scope of this review, which 
have been recently reviewed by Yuriev et al. [10]. In this review, the term ligand is used to refer to 
molecules capable of binding to a protein, such as metal ions, small organic (e.g., ATP) and inorganic 
compounds (e.g., NH4), peptides, and DNA/RNA; not large macromolecules such as proteins. 
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molecules capable of binding to a protein, such as metal ions, small organic (e.g., ATP) and inorganic
compounds (e.g., NH4), peptides, and DNA/RNA; not large macromolecules such as proteins.
2. In Silico Methods for the Prediction of Protein–Ligand Binding Sites and Their Associated
Binding Site Residues
In recent years, a large number of methods have been developed for the prediction of protein
function and protein–ligand binding sites. In this review, we discuss methods for the prediction of
protein–ligand binding sites and their associated binding site residues. These methods can be broadly
divided into sequence-based methods and structure-based methods.
2.1. Sequence-Based Methods
Sequence-based methods that predict protein–ligand binding sites and their interacting
ligand-binding site residues are those that use information from evolutionary conservation and/or
sequence similarity of homologous proteins. These methods can be broadly categorised into methods
that utilize machine learning (Multi-RELIEF [11], TargetS [12], LigandRF [13], and OMSL [14]),
methods that utilize only position-specific scoring matrices or PSSMs (INTREPID [15], DISCERN [16],
ConSurf [17], and ConFunc [18]) and graph-based methods such as Conditional Random Field
(CRF) [19]. The advent of including machine learning-based strategies into sequence-based methods
has resulted in improved method sensitivity. Machine learning is applied to PSSMs or multiple
sequence alignment-based properties using various alternative strategies, examples of which will
now be discussed.
Many of the sequence-based methods, such as Multi-RELIEF [11], deploy machine learning
methods to directly interpret multiple sequence alignment profiles. Multi-RELIEF works by
estimating the functional specificity of residues from a multiple sequence alignment using local
conservation properties. This method uses a machine learning technique called RELIEF [20] for
feature selection and weighting, using a binary classification to discriminate features from two classes.
A residue’s local specificity is determined by comparing the sequence with the closest homologue
in each of the two classes (same class and opposite class), using global sequence identity to find
the nearest neighbour sequence. If a residue has high local specificity to one pair of classes, it is
labelled as relevant. Furthermore, global sequence similarity is considered while scoring each residue
locally [11]. This results in the prediction of residues comprising a putative ligand binding site.
In contrast, LigandRFs [13] uses a random forest-based algorithm to predict protein–ligand
binding site residues. LigandRFs extracts 544 amino acid properties from the AAindex database [21],
which are then compared using the Matthews correlation coefficient. Each of the 544 properties are
ranked in relation to the number of their related properties. The properties are filtered to remove all
properties related to the top property; this removes redundant properties, which do not add any new
information. This process is continued through the list until 34 properties remain. These properties
relate to specific features crucial for determining putative binding site residues. The properties are
then applied over a seven residue sliding window of a PSI-BLAST [22] profile. A 1 ˆ 238 vector
is used to represent the 34 amino acid properties for each seven residue window. A random forest
is then utilized to learn the relationship between the large vector and the binding or non-binding
residue properties [13].
TargetS [12] is another machine learning-based method, but in contrast to other methods,
it utilizes secondary structure-based features in addition to sequence and PSSM-based features.
Currently, TargetS can predict ligand-binding sites for proteins that bind to nucleotides, metal ions,
DNA, and heme. The algorithm incorporates: protein conservation from a PSI-BLAST [22] PSSM
searching SwissProt [23], secondary structure features determined from the PSIPRED algorithm [24],
along with ligand-binding propensity of residues for each amino acid and each ligand category
(nucleotides, metal ions, DNA, and heme). These properties are subsequently combined using a
support vector machine (SVM) to predict ligand-binding site residues.
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2.2. Structure-Based Methods
Structure-based methods are those that exploit information from 3D atomic coordinates
(either predicted from sequence or derived from experiments). These methods either predict
the location of the ligand binding site and/or the putative ligand binding site residues. Such
methods can be further sub-categorised into: 1. Geometric-based methods (FINDSITE [25],
LigDig [26], LISE [27], PatchSurfer2.0 [28], Surflex-PSIM [29], EvolutionaryTrace [30], PRANK [31],
a Two-dimensional replica-exchange method [32], FMO-RESP [33], MapReduce approach [34],
TIFP [35], ProGolem [36], a Chemogenomics approach [37], ProPose [38], FunFHMMer [39],
mFASD [40], ProBis [41,42], and CavBase [43,44]); 2. Energetic methods (SITEHOUND [45],
VISCANA [46], SiteComp [47], and FTMap [48]); 3. Miscellaneous methods, which use information
from homology or template-based modelling (FunFOLD3 [3,4], COACH [49], COFACTOR [50],
GalaxySite [51], GASS [52], VISM-CFA [53], and PLIP [54]), Surface accessibility based methods
such as LigSiteCSC [55], in addition to Physicochemical properties exploited by Andersson and
colleagues [56]. Examples of different methods from each sub-category are now described, in addition
to their limitations.
2.2.1. Considerations When Employing Structure-Based Methods
Structure-based methods for prediction of protein–ligand binding sites have a number of
limitations, including the following: 1. If a 3D model or experimental structure cannot be obtained,
then it is not possible to make a prediction; in such cases the solution is to rely on purely
sequence-based methods. 2. If templates with the same fold as the target protein that contain
biologically relevant ligands cannot be detected, then it is not possible to make a prediction. 3. Most
prediction servers, such as COACH [49] and FunFOLD [3,4,57], utilize in-house structure prediction
pipelines to construct models for protein–ligand interaction predictions that may not always produce
the best quality model for every target, which may result in over- and under-predicted protein–ligand
binding sites. Nevertheless, despite these shortcomings, prediction methods are constantly under
development and improvements can be gauged via the rigorous independent blind assessment
scoring, described in Section 3.
2.2.2. Geometric Methods
FINDSITE [25] combines evolutionary and structural information to predict protein function,
identifying binding pockets based on binding site similarity between homologous structures. This
is undertaken by superposing templates onto the structure of interest and then finding sites where
ligands overlap. These results are then used to determine putative binding pockets and then
identifying the geometric centre of each pocket [25].
Similarly, LigDig [26] is another geometric method, but uses a ligand-centric approach, rather
than the traditional protein-centric approach to detect ligand-binding pockets in proteins. LigDig
utilizes a variety of information from ChEBI [58], PubChem, PDB [59], UniProt [23], and KEGG [60],
combined via a graph-based network to locate similar ligands along with their potential binding
partners. The method is available as a webserver and also uses text-based searches to find proteins
that may bind to a particular ligand of interest [26]. This results in the prediction of putative
protein–ligand binding sites.
In contrast to FINDSITE, LigDig, and the majority of geometric-based approaches, LISE [27]
is an algorithm that utilizes a novel concept of binding site-enriched protein triangles in order to
predict protein–ligand binding site locations. LISE uses ideas developed in a previous method, called
MotifScore [61], that determined motifs in a protein–ligand interaction database, composed of 6276
protein–ligand structures. The motifs contain the interactions between three atoms of a protein and
two atoms of a ligand. Thus, the three protein atoms of these motifs compose the “protein triangles”.
An additional step is to encapsulate the protein into a 3D grid of 1 Å size steps. Each vertex in this
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grid is then labelled as occupied or empty (with a 2.7 Å distance cutoff). For each empty grid point,
a grid point score is calculated, which equals the sum of the triangle scores. A large sphere of 11Å is
then centred on each empty vertex, and for each sphere, a sphere score is calculated, which is based
on the sum of the grid point scores for all empty grid points within the sphere. The sphere with the
highest score is determined as the putative ligand binding site [27].
2.2.3. Energetic Methods
SITEHOUND [45] is a widely used energetic method for the prediction of protein–ligand binding
sites, which utilizes a chemical probe to explore the surface of the protein structure, determining
regions that may have optimum energy for binding. SITEHOUND uses two different chemical
probes: a carbon probe to identify drug-like binding sites, and a phosphate probe to locate binding
sites for ligands having a phosphate group. Affinity maps or molecular interaction fields are
then used to describe the interaction of each probe with the protein surface. These affinity maps
are subsequently filtered to remove unfavourable interaction energies. The next step is to utilize
agglomerative hierarchical clustering to cluster the remaining interaction points based on their spatial
proximity. These clustered points are ranked by total interaction energy and result in a list of potential
ligand-binding pocket locations [45].
2.2.4. Miscellaneous Methods
A recent review by Petrey et al. [62] highlights the essential need for template-based 3D
modelling methods in the prediction of protein function [62]. The majority of these methods
predict putative protein–ligand binding sites and ligand binding site residues, while some methods
additionally predict Enzyme Commission Numbers (EC) and Gene Ontology (GO) terms. We have
developed a number of versions of a template-based method, called FunFOLD [3,4,57], which starts
with a 3D model of the target protein predicted from sequence, for example using the IntFOLD
server [63,64]. Each version of the algorithm has worked on the assumption that proteins with the
same fold that bind to similar biologically relevant ligands are likely to have similar binding sites.
The latest FunFOLD3 pipeline is composed of updated versions of two main algorithms, FunFOLD [4]
and FunFOLDQA [1], and it produces output comprising predicted EC and GO terms, ligand-binding
site residues, putative ligands, binding site quality scores, and per-atom p-values to comply with the
CAMEO-LB format [65].
FunFOLD firstly superposes, using TM-align [66], a list of structural templates containing
biologically relevant ligands (determined using the BioLip database [67]) onto the target 3D model.
Template-model superpositions with a TM-score ě 0.4 are retained. The next step is to superimpose
all retained templates onto the target model and assign ligands from the template files into clusters
using agglomerative hierarchical clustering. The identified ligand clusters are located at the potential
ligand-binding sites. Ligands are determined to be components of a cluster if the contact distance
is less than or equal to 0.5 Å plus the Van der Waal radii of the contacting atoms. The putative
ligand-binding site containing the largest ligand cluster is determined to be the most probable
ligand-binding site of the protein. The identification of the putative ligand-binding site residues is
carried out via a residue voting method [3,4].
The next component of the FunFOLD3 pipeline is the FunFOLDQA algorithm [1], which
evaluates the quality of FunFOLD predictions, subsequently producing a set of confidence scores. The
algorithm outputs scores for five sequence- and structure-based features that are combined using a
neural network, outputting predicted Binding-site Distance Test (BDT) [68] and Matthews Correlation
Coefficient (MCC) [69] scores. The FunFOLD3 [57] pipeline additionally outputs a set of per-residue
binding probability scores to comply with the CAMEO-LB format [65]. Furthermore, the FunFOLD3
method outputs a putative ligand binding site, putative ligand binding site residues, putative ligands
that may bind to the target protein, along with predicted EC and GO [70,71] terms (see Section 4) for
each target protein [3,4].
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The COACH [49] method is similar to FunFOLD and is one of the most accurate ligand-binding
site prediction methods that utilizes both sequence and structural homology in the prediction
pipeline. The structure component (TM-SITE) of the pipeline firstly locates putative ligand-binding
pockets using ConCavity [72]. TM-SITE then uses fifteen residues within the binding pocket structure
to search against the BioLip database to find structures containing similar binding pockets, in addition
to searching for similar structures (using TM-align [66]) to the target protein containing biologically
relevant ligands within BioLip [67]. All templates and sub-structural templates are superposed onto
the target and scored based on empirically determined cutoffs. Ligand binding site residues are
then determined using a similar strategy to FunFOLD [4], but using average linkage clustering and
assigning a confidence score to each predicted ligand binding site residue. The sequence component
of the algorithm, S-SITE, uses residue conservation of sequence profiles to predict ligand binding
site residues, subsequently scoring the confidence of each predicted binding site residue. COACH
then uses a consensus of predictions, combining the results from TM-SITE and S-SITE along with
COFACTOR [50], FINDSITE [25], and ConCavity [72]. Similar to FunFOLD3, COACH predicts a
putative ligand binding site, putative ligand binding site residues, putative ligands that may bind to
the target protein, along with predicted EC and GO terms for each target protein.
A somewhat alternative approach to that of FunFOLD and COACH is used by GASS [52]. GASS
(Genetic Active Site Search) is developed by Izidoro et al. [52], who have employed a genetic algorithm
to predict ligand binding site residues for putative enzymes. Their method takes a list of templates
from the CSA [73] with predefined binding site residues. They then simulate evolutionary effects
(crossover and mutations) over this population of templates, according to predefined mutational
probabilities, for a specific number of user-defined generations. The resultant binding site residue
predictions are then assessed using a fitness function, which ranks individual sets of predictions.
The fitness function is similar to an RMSD (root-mean-square deviation) for the ligand binding site
residues, with the main difference being that the square distance of the results is not averaged [74].
Several structure-based methods that exploit surface accessibility have also been developed,
such as LIGSITEcsc [55]. LIGSITEcsc uses the Connolly surface in its ligand binding site prediction
protocol. The first step of the protocol is to encapsulate the protein structure into a 3D grid of 1 Å
steps. In the second step of the protocol, each point in the grid is labelled as either protein, surface,
or solvent. In the third step, the Connolly algorithm is utilized to calculate the solvent-excluded
surface. In the fourth step, surface-solvent-surface events are then determined. In the fifth step, if the
surface-solvent-surface events in a grid exceed a minimum threshold, set to six grid locations, this is
determined to be a pocket. Each pocket cluster is then ranked in relation to the number of grid points
within the cluster. The top three pockets are then retained. In the final step, the top three pockets are
re-ranked in relation to the conservation of pocket surface residues [55].
Further structure-based methods have used physiochemical properties to determine ligand
binding cavities. For example, the method by Andersson et al. (2010, [56]) works initially by
identifying solvent accessible patches. In the second step, data is collected from each patch based
on 408 surface descriptors, divided into eight categories. These descriptors include neighbouring
amino acids, secondary structure, polarity of adjacent amino acids, close hydrogen bond donors
and acceptors, electrostatic potential, shape, polarity, and flexibility. In the third step, the descriptor
results are divided into bins and scaled to be usable for Principal Component Analysis (PCA). In the
fourth step, PCA is carried out and the relationships between pockets are analysed. This method
produces results for all putative pockets, leaving the user to determine which pocket is the most
suitable ligand binding pocket for their particular task [56].
3. Methods for the Evaluation of Protein–Ligand Binding Site Residue Predictions
Assessment of protein–ligand binding site residue predictions have been carried out in
CASP [8,75,76] and CAMEO [65] using a number of different scores, which include the Matthews
Correlation Coefficient (MCC) [69] and the Binding-site Distance Test (BDT) score [68]. The MCC
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score is a statistical measure that compares observed ligand binding site residues to predictions by
assessing the number of residues assigned as true positives, false positives, true negatives, and false
negatives. This results in a score between ´1 and 1, with scores close to zero representing random
predictions and scores close to one representing near perfect predictions. The MCC score may only
be a good choice for scoring sequence-based predictions, when no structural information is available,
as the MCC score does not consider the 3D nature of the protein within the scoring metric.
To overcome the limitations of the MCC score, we developed the Binding-site Distance Test
(BDT score) [68]. The BDT score utilizes the distance in 3D space between a predicted ligand binding
site residue and an observed ligand binding site residue in the scoring process. The BDT score has
a range from zero to one, where scores close to zero represent random predictions and scores close
to one represent near perfect predictions. Predicted ligand binding sites closer in 3D space to the
observed ligand binding site are scored higher than ligand binding sites predicted farther from the
observed ligand binding site. In the CASP9 and CASP10 FN assessments [75,76], the BDT score was
used by the official assessors in addition to the MCC score. Furthermore, the BDT score is used in the
CAMEO [65] project as one of the standard assessment metrics.
4. Prediction of Enzyme Commission Numbers (EC) and Gene Ontology Terms (GO)
In addition to the determination of protein–ligand binding sites and their associated binding site
residues, it is also useful to determine the likely function of a protein. Functionality can be generally
assigned using Gene Ontology (GO) terms [70,71], or more specifically for enzymes, using Enzyme
Commission numbers (EC).
The Gene Ontology Commission was formed in 2000 [70] to develop a controlled vocabulary
for describing genes, as a result of the large increase of sequence data from genomics projects.
Gene Ontology (GO) terms, often referred to as a shared vocabulary for genes, comprise over
40,000 terms. GO terms are broadly divided into three categories: cellular components, molecular
function (a weak analogy to EC codes), and biological processes, which are further subdivided in
a hierarchical graph-like structure. Each protein has the potential to be assigned to multiple GO
classes and sub-classes. Moreover, each GO term has a unique serial number, in addition to a textual
description [70,71].
The Enzyme Commission (EC) was set up in 1956 as part of the International Union of Pure
and Applied Chemistry (IUPAC), publishing the first version of EC numbers in 1961. Today, the
EC classification is maintained by the Nomenclature Committee of the International Union for
Biochemistry and Molecular Biology (NC-IUBMB) and the enzyme list is curated and maintained
by the Tipton group at Trinity College Dublin [77]. The list officially classifies enzymes by the
overall reactions they catalyse, in order to reduce the ambiguous names enzymes previously acquired.
Enzymes are hierarchically classified by four-digit EC numbers. The first number designates the
broad classification into: 1. Oxidoreductases; 2. Transferases; 3. Hydrolases; 4. Lyases; 5. Isomerases;
and 6. Ligases. The second class usually designates the type of molecule involved in the reaction.
The third class designates the type of reaction involved, while the fourth class is essentially a serial
number, which has been utilized to differentiate enzymes within the subclasses [77].
Recently, a number of methods have been developed specifically to predict GO and EC
terms. A large number of these methods have been developed as rapid methods that utilize
sequence information only. The majority of methods predict function based on Gene Ontology (GO)
terms (which include: INGA [78], EFI-EST [79], SIFTER [80], GEO2Enrichr [81], PANNZER [82],
and PILL [83]) with fewer utilizing EC numbers (EFI-EST [79] and DomSign [84]) for functional
annotation. Furthermore, a number of structure-based methods for the prediction of protein–ligand
binding sites have incorporated methods for predicting GO and EC terms, including COACH [49]
and FunFOLD3 [3,4,57] (See Section 2.2.4). However, as these methods build 3D models as
part of their prediction pipeline, they are somewhat more computationally intensive than the
sequence-only methods.
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The prediction of EC and GO terms, in addition to the prediction of protein–ligand binding sites
and their associated ligand binding site residues, further enriches the information that can be gleaned
for a particular protein. This highlights the biological need for in silico methods in function prediction
and rational drug design, contributing to future in silico, in vitro, and in vivo experiments for both
biomedical and bioenvironmental research applications.
5. CASP, CAFA, and CAMEO—Their Role in Development and Assessment of Protein–Ligand
Binding Site Prediction Algorithms
The development of methods for the prediction of protein–ligand binding sites and function
prediction has been driven in recent years as a direct result of community wide prediction
experiments, such as the Critical Assessment of Techniques for Protein Structure Prediction
(CASP) [8,75,76], the Continuous Automated Model EvaluatiOn (CAMEO) project [65], and the
Critical Assessment of Function Annotation (CAFA) [85].
Ligand binding site residue prediction was first introduced in CASP8 (as the FN category) [8],
with the concept then involving the prediction of putative ligand binding site residues, which may
functionally interact with a biologically relevant bound ligand. Since it is not presently possible
to clearly distinguish between catalytic, active, and binding site residues, using computational
methods, the algorithms simply predict protein–ligand binding site residues. In CASP8, the top
performing methods LEE [86] and 3DLigandSite [87] used a similar prediction strategy, combining
information from homology models along with the templates used to construct the models
that contained biologically-relevant bound ligands. In CASP9 [75] and CASP10 [76], successful
methods for the prediction of protein–ligand binding sites built upon and further refined this
template-based approach.
Following on from CASP10 [76], it was decided to move the FN prediction category
to a continuous assessment strategy, due to the lack of available targets containing bound
biologically-relevant ligands during the short three month CASP prediction period. Hence, the
CASP FN category moved to the CAMEO continuous assessment project [65]. The move to fully
automated assessment resulted in a change of prediction format, with the additional prediction of
which ligand category (I—Ion, O—Organic, N—Nucleotide, and P—Peptide) a protein may bind.
Participating servers must also provide a p-value representing the likelihood that each residue
(or atom) binds a ligand in each category. The CAMEO assessment runs weekly on structures
containing biologically-relevant ligands using target sequences of structures that are on hold for
release by the Protein Data Bank (PDB) [65]. The CAMEO project provides a better picture of how
each method performs on a large and diverse dataset, containing a wide variety of proteins bound to
a wide variety of ligands.
Complementary to CAMEO and CASP is the CAFA [85] experiment, which has also been a major
driver for the development of function prediction methods. The goal of CAFA is to functionally
annotate proteins on a large scale using GO terms [70,71]. The CAFA1 dataset contained >48,000
proteins as of October 2010, for which predictions were made. Following the prediction season,
methods were evaluated on 866 of the proteins, which had acquired annotations over the eleven
months following the close of the prediction season. Methods that compete in CAFA [85] include
a large number of the methods described in the proceeding sections, comprising sequence-based
methods, structure-based methods and combinations of both.
6. The Application of in Silico Protein–Ligand Binding Site Prediction Methods: Impact on
in Vitro Studies
In addition to the theoretical and computational uses of protein–ligand binding site prediction
algorithms previously highlighted, methods for the prediction of protein–ligand binding sites have
been used in numerous in silico/in vitro studies. These studies have focused on a wide range
of subjects as diverse as calcium-binding proteins [88], olfactory proteins [89], the CollagenQ
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protein–COLQ [90], human PE5 proteins [91], barley powdery mildew proteins [92,93], and spider
mite glutathione S-transferases [94], which have led to biological findings of relevance to the study of
health and disease and to food security [88–95].
We firstly describe a number of case studies from research projects investigating proteins
implicated in health and disease. The first study [88] analysed a large number of calcium-binding
proteins present in biological systems on a genome-wide scale, termed: calciomics. As calcium
impacts every aspect of cellular life, Ca2+ binding proteins can be implicated in a wide range of
diseases, thus this in silico study investigates their potential roles [88]. Another in silico proteome-wide
study, this time on PE5 proteins (plasma membrane transporters and receptors) from the human
proteome, was undertaken by Dong et al. to correct misannotations of these highly misannotated
proteins [91]. Furthermore, Don and Riniker undertook in silico analysis of olfactory receptor proteins,
members of the G-protein coupled receptor (GPCR) family, to enable the future design of therapeutics
targeting olfactory-related and GPCR-related diseases [89]. In addition, Arredondo et al. combined
modelling and the prediction of protein–ligand binding sites with in vitro studies to investigate a
number of COLQ mutants and determine their mode of action [90]. These COLQ mutants cause
human deficiency of endplate acetylcholinesterase, which results in the impairment of the interaction
of COLQ with the basal lamina. This leads to a reduction in the duration of synaptic activation, which
can lead to synaptic-related diseases.
Focusing on projects that have implications on food security, we highlight a study on the
barley powdery mildew proteome [92]. This research involved the combination of proteogenomic
along with structural and functional (protein–ligand binding sites and binding site residues)
predictions, in order to investigate the pathogenic properties of barley powdery mildew. Basically,
IntFOLD [63,64] was used to construct models for the entire proteome, which were validated utilizing
ModFOLD3 [63]. Subsequently, FunFOLD [4] was used to predict protein–ligand binding sites
for these models. This resulted in interesting conclusions about the Blumera graminis f.sp. hordei
proteome. Firstly, the proteins are structurally diverse and remotely homologous to known proteins,
potentially containing novel folds, as it was only possible to model six proteins with a model quality
score above 0.4. Secondly, FunFOLD was able to help in the assignment of functionality for these six
proteins, all were carbohydrate-binding and probably glycosyl hydrolases. Moreover, this putative
functionality was experimentally elucidated, highlighting the utility of protein–ligand interaction
methods to aid functional elucidation [92]. An additional study with relevance to food security from
Pavlidi et al. [94] involves the functional characterization of a particular glutathione S-transferase,
which may enable the two-spotted spider mite (Tetranychus urticae) to have acaricide/insecticide
resistance. Tetranychus urticae has been shown to be one of the most damaging agricultural pests
globally. The spider mite has three glutathione S-transferase enzymes; TuGSTd10, TuGSTd14, and
TuGSTm09. Subsequently, assays determined that TuGSTd14 was the glutathione S-transferase
involved in the acaricide/insecticide resistance. The structure of TuGSTd14 was predicted using
IntFOLD [63,64] and protein–ligand binding site residues predicted using FunFOLD [3]. These
in silico results were utilized to determine the key structural characteristics, including residues that
were involved in the substrate binding specificity [94].
The studies described above, on proteins related to health and disease [88–91] in addition to
food security [92–94] highlight the utility of protein–ligand binding site prediction methods, which
can contribute to the interpretation of the function and the biochemical interactions of key proteins
and enzymes, impacting our ability to tackle urgent global problems.
7. Conclusions
A large number of predictive methods are available to predict and analyse protein–ligand
binding sites. These methods incorporate different approaches, providing numerous different data
types ranging from lists of ligand binding site residues, 3D atomic coordinates of ligand binding sites,
lists of putative binding ligands, EC, and GO terms. The results produced by these in silico methods
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can be useful to generate new hypotheses and drive further experiments that can impact on major
challenges in biology.
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